49 articles, transcripts, and reports
Scienture Holdings Inc (MEDS) posted Q4 2025 basic and diluted EPS of -$2.70.
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry by offering advanced solutions that…
Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform that digitalizes the retail pharmacy experience. The company has a growing network of…
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The company’s full-year net loss widened…
Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy experience. Having strengthened its foothold…
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of its efforts to…
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such move being the…
TRxADE HEALTH Inc (NASDAQ: MEDS) Q1 2023 earnings call dated May. 15, 2023 Corporate Participants: Prashant Patel — Interim Chief Financial Officer Suren Ajjarapu — Chairman and Chief Executive Officer…
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that operates as an integrated drug procurement and delivery platform. It is focused on digitalizing…
TRxADE HEALTH Inc (NASDAQ:MEDS) Q4 2022 Earnings Call dated Mar. 27, 2023. Corporate Participants: Prashant Patel — Chief Financial Officer Surendra Ajjarapu — Founder, Chairman and Chief Executive Officer…
